Additional file 7: Table S4. of Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/Additional_file_7_Table_S4_of_Axitinib_and_sorafenib_are_potent_in_tyrosine_kinase_inhibitor_resistant_chronic_myeloid_leukemia_cells/4377584
下载链接
链接失效反馈官方服务：
资源简介：
Anti-GAB2 IP of Imatinib, Axitinib and Sorafenib vs DMSO treated cells. SILAC ratios are normalized to GAB2. Only sites with localization probabilities greater 0.75 and Andromeda scores greater 40 are shown. PEP: posterior error probability. (XLSX 12 kb)
创建时间：
2016-12-15
